Abstract

Mitogen-activated protein kinases (MAPKs) are essential for proper cell functioning as they regulate many molecular effectors. Careful regulation of MAPKs is therefore required to avoid MAPK pathway dysfunctions and pathologies. The mammalian genome encodes about 200 phosphatases, many of which dephosphorylate the MAPKs and bring them back to an inactive state. In this review, we focus on the normal and pathological functions of dual-specificity phosphatase 9 (DUSP9)/MAP kinase phosphatases-4 (MKP-4). This cytoplasmic phosphatase, which belongs to the threonine/tyrosine dual-specific phosphatase family and was first described in 1997, is known to dephosphorylate ERK1/2, p38, JNK and ASK1, and thereby to control various MAPK pathway cascades. As a consequence, DUSP9 plays a major role in human pathologies and more specifically in cardiac dysfunction, liver metabolic syndromes, diabetes, obesity and cancer including drug response and cell stemness. Here, we recapitulate the mechanism of action of DUSP9 in the cell, its levels of regulation and its roles in the most frequent human diseases, and discuss its potential as a therapeutic target.

Highlights

  • INSERM, MIRCADE Team, UMR1035 Biothérapie des Maladies Génétiques, Désordres Inflammatoires et Cancer, BMGIC, Université de Bordeaux, 146 Rue Léo Saignat, F-33000 Bordeaux, France; Citation: Khoubai, F.Z.; Grosset, C.F

  • This catalytic activity of with of increasing concentrations of dual-specificity phosphatase 9 (DUSP9) in the dose-dependent blockade is effectively inhibited by sodium vanadate, which is an inhibitor of protein tyrosine phosof ERK2 target phosphorylation such as stathmin [18]

  • DUSP9 by bone morphogenetic protein 4 (Bmp4) is accompanied by inhibition of ERK pathway activity and downregulation of its targets Egr1 and Fos (Figure 2). This DUSP9-mediated dephosphorylation was not observed for p38 and JNK, showing its specificity for ERK1/2 signaling which is crucial for the renewal and differentiation of mouse embryonic stem cells (mESCs) [31]

Read more

Summary

General Introduction

The mitogen-activated protein kinase (MAPK) signaling pathways are crucial in cell function and homeostasis. MAPK signaling and ERK kinases play a key role in cancer by regulating proliferation, migration, angiogenesis and metastasis [8]. Typical DUSPs are the best characterized within the DUSP family [20] and this comprises the typical DUSP named DUSP9 or MKP4, which was first described in 1997 by Muda and collaborators [18] This 42-kDa protein dephosphorylates several substrates including JNK, p38, the MAPKKK apoptosis signal-regulating kinase 1 (ASK1) and ERK1/2 with a high specificity for ERK kinases [3,18].

General
DUSP9 in Embryonic Stem Cell Pluripotency and Sex Differences
DUSP9 and Metabolic Diseases
DUSP9 and Cardiac Disease
DUSP9 in Cancers
Main Results
Breast Cancer
Colorectal Cancer
Gastric Cancer
Liver Cancer
Lung Cancer
Kidney Cancer
Skin Cancer
DUSP9 Is the Target for Therapy
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.